MNTA - Momenta Pharmaceuticals EPS misses by $0.28 beats on revenue February, 26 2020 07:08 AM Momenta Pharmaceuticals Inc. Momenta Pharmaceuticals (NASDAQ:MNTA): Q4 GAAP EPS of -$0.85 misses by $0.28.More news on: Momenta Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...